Summarize with ChatGPT
Regenerative pain medicine continues to reshape patient care by promoting tissue repair rather than simply masking symptoms. Today’s clinicians have access to multiple regenerative pathways — including shockwave therapy and biologic injections — that activate healing through different mechanisms yet share the same goal: restoring healthy structure and function.
SoftWave Therapy — an evidence-based extracorporeal shockwave therapy (ESWT) — can serve as a standalone regenerative treatment or a synergistic partner to injection-based biologics. This flexibility allows practices with or without injection capability to deliver meaningful, healing-led outcomes.
How Shockwave Therapy Supports Tissue Repair
ESWT delivers mechanical energy into musculoskeletal tissues, activating key biological processes:
- Angiogenesis and microcirculation
- Stem cell recruitment
- Growth factor release
- Collagen remodeling
- Inflammation modulation and pain reduction
These regenerative responses translate into proven clinical improvements:
📌 ESWT more than doubled success rates in chronic plantar fasciitis — with sustained improvement and no adverse events. (Sun et al., 2017)
📌 In knee osteoarthritis, ESWT significantly improved pain and function, with benefits lasting up to 12 months. (Wang et al., 2019)
Because shockwave initiates healing without tissue disruption, it offers broad versatility for soft tissue and joint-related conditions
SoftWave Therapy: Broad-Focused Regeneration
SoftWave Therapy uses a patented broad-focused applicator engineered to distribute energy wide and deep — stimulating tissue without causing microtrauma.
Clinical advantages include:
- Quick, non-invasive treatment experienc
- Immediate pain relief commonly reported
- Wide treatment zone — less technician dependency
- Patient-guided feedback to identify painful lesions
- No consumables or biologic processing required
FDA-clearances support its application in orthopedics, sports medicine, physical therapy, chiropractic, podiatry, and urology.
Injection-Based Regenerative Therapies: Direct Biologic Delivery
These therapies introduce healing cells or biologic factors directly into damaged structures:
Platelet-Rich Plasma (PRP)
Growth factor–rich concentration from patient’s blood
• Shown to improve pain and function in knee OA vs. saline and HA (Filardo et al., 2021)
Bone Marrow Aspirate Concentrate (BMAC)
Mesenchymal stem/stromal cell-based concentrate
• Improved outcomes in knee OA vs. HA injections (Belk et al., 2023)
Prolotherapy
Irritant solution used to trigger localized repair
• Comparable OA improvements to other injections (Zhao et al., 2022)
These modalities are valuable where direct biologic support is necessary.
How They Compare
| Aspect | SoftWave Therapy | Biologic Injections |
|---|---|---|
| Modality | External regenerative energy | Needle-based biologics |
| Mechanism of action | Mechanotransduction | Biologic delivery or inflammatory trigger |
| Tissue disruption | None | Minimal, needle entry required |
| Onset of benefit | Often immediate pain reduction; continued healing over weeks | Days to weeks; depends on biologic and condition |
| Visit burden | Short, no prep or recovery | Prep, post-care, short-term soreness |
| Ideal scenarios | Soft-tissue injury, OA, diagnostic localization, patients not ready for injections | Advanced degeneration requiring structural biologic repair |
| Integration | Stands alone or enhances injections | Often paired with SoftWave for improved environment & continuity |
Key point:
Both are regenerative. Their complementary mechanisms give clinicians more treatment options.
Why Many Clinics Use Both
Integrated regenerative programs commonly apply SoftWave:
✔ Before injections — reduce pain and improve local perfusion
✔ Between injection visits — amplify cell signaling during healing
✔ As a maintenance solution — extend positive outcomes long-term
Patients benefit from:
- Earlier relief = stronger engagement
- Continued progress = confidence in the plan
- Reduced friction = better adherence and outcomes
SoftWave expands regenerative access when biologics are not used, and enhances biologic success when they are.
Practical Fit Across Specialties
| Provider Type | How SoftWave Helps |
|---|---|
| Regen & sports med clinics using injections |
Boosts biologic effectiveness and maintains healing momentum |
| PTs, chiros, podiatrists not using injections |
Delivers a full regenerative pathway without needles |
| Entry-point orthopedic & MSK practices |
Provides a scalable first-line regenerative solution |
SoftWave = regeneration made accessible.
Where SoftWave Fits in Regenerative Care
SoftWave is utilized for:
- Musculoskeletal pain & tendinopathies
- Plantar fasciitis & foot/ankle pathology
- Osteoarthritis and joint degeneration
- Chronic wound healing
- Pelvic health and urologic indications
Supported by peer-reviewed clinical evidence and continued innovation.
Provide Regenerative Care with SoftWave
Regenerative medicine isn’t limited to one approach.
Healing can be driven mechanically, biologically, or in combination — depending on the patient and condition.
SoftWave Therapy enables more providers to deliver regenerative care, while improving the impact of biologic therapies where they are used.
Two regenerative pathways. One mission: Help the body heal itself.
Explore how SoftWave Therapy can strengthen your regenerative treatment model — wherever you start.
Schedule a demo and Become a SoftWave Provider today.
